Sacubitril Hemicalcium
沙库比曲半钙盐 | Sacubitril Hemicalcium | 1369773-39-6 | N'ime ụlọ |
沙库比曲钠盐 | 149690-05-1 | N'ime ụlọ | |
LCZ-4 | 1426129-50-1 | N'ime ụlọ | |
LCZ-7 | 1012341-48-8 | N'ime ụlọ | |
LCZ-8 | 1012341-50-2 | N'ime ụlọ | |
LCZ-9 | 149690-12-0 | N'ime ụlọ |
ndabere
AHU-377 hemicalcium nnu bụ nnu hemicalcium nke AHU-377.Ọ bụ ihe mgbochi nke neprilysin nwere uru IC50 nke 5 nM [1].
AHU-377 na angiotensin II AT1 antagonist valsartan dere LCZ696 na nha 1: 1 molar.LCZ696 bụ angiotensin receptor neprilysin inhibitor.Ọ nwere ike ibelata ọbara mgbali ma bụrụkwa ọgwụ ọhụrụ maka ọgwụgwọ nkụda obi.AHU-377 bụ pro-ọgwụ, ọ nwere ike gbanwee site enzymatic cleavage nke ethyl ester n'ime arụ ọrụ ụdị LBQ657.A na-akọ na AHU-377 (30 na 100 mg / kg, PO) nwere ike ịkpata mmetụta antihypertensive n'ụzọ dabere na dose na oke DAHI-SS.Ma na DOCA-nnu hypertensive oke, ọ na-egosi mbelata adịghị ike [2, 3].
Ntụaka:
[1] Ksander GM, Ghai RD, deJesus R, Diefenbacher CG, Yuan A, Berry C, Sakane Y, Trapani A. Dicarboxylic acid dipeptide inhibitors endopeptidase inhibitors.J Med Chem.1995 Mee 12;38 (10): 1689-700.
[2] Voors AA, Dorhout B, van der Meer P. Ọrụ nwere ike nke valsartan + AHU377 (LCZ696) na ọgwụgwọ nke nkụda obi.Echiche ndị ọkachamara nyocha ọgwụ.2013 Ọgọst; 22 (8): 1041-7 .
[3] Laxminarayan G Hegde, Cecile Yu, Cheruvu Madhavi et al.Ntụnyere arụmọrụ nke AHU-377, onye na-egbochi neprilysin dị ike, n'ụdị oke abụọ nke ọbara mgbali elu dabere na olu.BMC Pharmacology 2011, 11 (Nkwadebe 1):P33.
Ọdịdị chemical
![2018 GMP-2](http://www.cz-pharma.com/uploads/beaa7119.jpg)
![原料药GMP证书201811(captopril ,thalidomide etc)](http://www.cz-pharma.com/uploads/15b802ef.jpg)
![GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co](http://www.cz-pharma.com/uploads/40ac545a.jpg)
![FDA-EIR-Letter-201901](http://www.cz-pharma.com/uploads/FDA-EIR-Letter-201901.jpg)
![Quality management1](http://www.cz-pharma.com/uploads/Quality-management1.png)
Atụmatụ18Ọrụ nlebanya na-agbanwe agbanwe nke akwadoro4, na6A na-akwado ọrụ ngo.
![Quality management2](http://www.cz-pharma.com/uploads/Quality-management2.png)
Usoro njikwa ogo mba ụwa dị elu etinyela ntọala siri ike maka ire ahịa.
![Quality management3](http://www.cz-pharma.com/uploads/Quality-management3.png)
Nlekọta dị mma na-aga n'ihu na usoro ndụ nke ngwaahịa ahụ niile iji hụ na ịdịmma na mmetụta ọgwụgwọ.
![Quality management4](http://www.cz-pharma.com/uploads/Quality-management4.png)
Ndị otu Regulatory Affairs ndị ọkachamara na-akwado ịdịmma chọrọ n'oge ngwa na ndebanye aha.
![cpf5](http://www.cz-pharma.com/uploads/cpf5.png)
![cpf6](http://www.cz-pharma.com/uploads/cpf6.png)
Ahịrị nkwakọ ngwaahịa Korea Countec
![cpf7](http://www.cz-pharma.com/uploads/cpf7.png)
![cpf8](http://www.cz-pharma.com/uploads/cpf8.png)
Taiwan CVC ahịrị nkwakọ ngwaahịa
![cpf9](http://www.cz-pharma.com/uploads/cpf9.png)
![cpf10](http://www.cz-pharma.com/uploads/cpf10.png)
Line CAM Board Ịtali
![cpf11](http://www.cz-pharma.com/uploads/cpf11.png)
Igwe na-akpakọrịta Fette German
![cpf12](http://www.cz-pharma.com/uploads/cpf12.png)
Ihe nchọpụta mbadamba ihe ngosi nke Japan
![cpf14-1](http://www.cz-pharma.com/uploads/cpf14-1.png)
Ụlọ njikwa DCS
![International cooperation](http://www.cz-pharma.com/uploads/International-cooperation.jpg)
![Domestic cooperation](http://www.cz-pharma.com/uploads/Domestic-cooperation.jpg)